260 related articles for article (PubMed ID: 9401775)
1. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
2. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
[TBL] [Abstract][Full Text] [Related]
3. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
Costall B; Naylor RJ
Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
[TBL] [Abstract][Full Text] [Related]
4. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
Cheng CH; Costall B; Kelly ME; Naylor RJ
Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
[TBL] [Abstract][Full Text] [Related]
5. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
[TBL] [Abstract][Full Text] [Related]
6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
7. Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.
Kato S; Matsuda N; Matsumoto K; Wada M; Onimaru N; Yasuda M; Amagase K; Horie S; Takeuchi K
Pharmacol Res; 2012 Sep; 66(3):226-34. PubMed ID: 22699012
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
Misane I; Johansson C; Ogren SO
Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of the 5-HT4 receptor.
Costall B; Naylor RJ
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():11-8. PubMed ID: 8201242
[TBL] [Abstract][Full Text] [Related]
10. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
Yamano M; Kamato T; Miyata K
Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
[TBL] [Abstract][Full Text] [Related]
11. Effects of agonists and antagonists of some serotonin-receptor subtypes on memory and their modulation by the 5-HT-uptake inhibitor fluoxetine.
Petkov VD; Kehayov R
Acta Physiol Pharmacol Bulg; 1994; 20(3-4):83-90. PubMed ID: 7645408
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
Tuladhar BR; Kaisar M; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
[TBL] [Abstract][Full Text] [Related]
13. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
[TBL] [Abstract][Full Text] [Related]
14. 5-HT induces cAMP production in crypt colonocytes at a 5-HT4 receptor.
Albuquerque FC; Smith EH; Kellum JM
J Surg Res; 1998 Jul; 77(2):137-40. PubMed ID: 9733600
[TBL] [Abstract][Full Text] [Related]
15. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
16. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of 5-HT4 receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheep.
Plaza MA; Arruebo MP; Murillo MD
Br J Pharmacol; 1997 Mar; 120(6):1144-50. PubMed ID: 9134228
[TBL] [Abstract][Full Text] [Related]
18. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
19. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
Ge J; Barnes NM
Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
[TBL] [Abstract][Full Text] [Related]
20. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
